Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction

Chiara Masetti¹, Alessio Aghemo^{1

2}

Affiliations

¹ Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital IRCCS, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Editorial

Chiara Masetti et al. Liver Int. 2021 Jul.

. 2021 Jul;41(7):1441-1442.

doi: 10.1111/liv.14967.

Chiara Masetti¹, Alessio Aghemo^{1

2}

¹ Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Research Hospital IRCCS, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.

No abstract available

Comment on

Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life.
Asselah T, Loureiro D, Le Gal F, Narguet S, Brichler S, Bouton V, Abazid M, Boyer N, Giuly N, Gerber A, Tout I, Maylin S, Bed CM, Marcellin P, Castelnau C, Gordien E, Mansouri A. Asselah T, et al. Liver Int. 2021 Jul;41(7):1509-1517. doi: 10.1111/liv.14950. Epub 2021 Jun 8. Liver Int. 2021. PMID: 33999515

1. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18:997-1003.
1. Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: systematic review and metanalysis. J Hepatol. 2020;73:523-532.
1. Rizzetto M, Hamid S. The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal. Liver Int. 2021;41(1):16-19.
1. Yurdaydın C, Idilman R, Bozkaya H, et al. Natural history and treatment of chronic delta hepatitis. J Viral Hepat. 2010;17:749-756.
1. Koh C, Da BL, Glenn JS. HBV/HDV coinfection: emerging therapeutic options for a challenging disease. Clin Liv Dis. 2019;23(3):557-572.